v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating activities      
Net income $ 5,286 $ 4,526 $ 4,302
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:      
Depreciation and amortization 358 296 220
Noncash lease expense 118 109  
Stock-based compensation 622 567 564
Deferred income tax expense (benefit) (157) 17 (226)
Charitable Contribution 589    
Gain related to the Charitable Contribution (122)    
Contingent consideration fair value adjustments 23 53 65
Other investment gains (244) (30) (50)
Net (gains) losses within consolidated sponsored investment products (501) (254) 149
Net (purchases) proceeds within consolidated sponsored investment products (2,282) (1,746) (1,938)
(Earnings) losses from equity method investees (148) (116) (94)
Distributions of earnings from equity method investees 32 70 30
Changes in operating assets and liabilities:      
Accounts receivable (313) (433) 4
Investments, trading 160 (21) 179
Other assets (60) 141 (223)
Accrued compensation and benefits 487 58 (230)
Accounts payable and accrued liabilities (115) (111) 43
Other liabilities 10 (242) 280
Net cash provided by/(used in) operating activities 3,743 2,884 3,075
Investing activities      
Purchases of investments (359) (693) (327)
Proceeds from sales and maturities of investments 187 417 449
Distributions of capital from equity method investees 183 136 24
Net consolidations (deconsolidations) of sponsored investment funds (71) (110) (51)
Acquisitions, net of cash acquired   (1,510) (699)
Purchases of property and equipment (194) (254) (204)
Net cash provided by/(used in) investing activities (254) (2,014) (808)
Financing activities      
Proceeds from long-term borrowings 2,245 992  
Repayments of long-term borrowings   (1,000)  
Cash dividends paid (2,260) (2,096) (1,968)
Repurchases of common stock (1,809) (1,911) (2,087)
Net proceeds from (repayments of) borrowings by consolidated sponsored investment products 51 111 40
Net (redemptions/distributions paid)/subscriptions received from noncontrolling interest holders 2,051 1,458 1,263
Other financing activities (34) (137) (13)
Net cash provided by/(used in) financing activities 244 (2,583) (2,765)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 102 54 (93)
Net increase/(decrease) in cash, cash equivalents and restricted cash 3,835 (1,659) (591)
Cash, cash equivalents and restricted cash, beginning of year 4,846 6,505 7,096
Cash, cash equivalents and restricted cash, end of year 8,681 4,846 6,505
Supplemental disclosure of cash flow information:      
Interest 183 193 177
Income taxes (net of refunds) 1,308 1,168 1,159
Supplemental schedule of noncash investing and financing transactions:      
Issuance of common stock 515 549 652
PNC preferred stock capital contribution   60 58
Charitable Contribution of an investment (589)    
Increase/(decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds $ (1,414) $ (1,292) $ (560)